GEN-MKT-18-7897-A
Aug 17, 2023 | Blogs, Pharma, QTRAP / Triple Quad | 0 comments
Read time: 3 minutes
Investing in a new LC-MS system is not an easy decision, especially if you have a range of analytical requirements in your laboratory. This blog is part of a series intended to help you choose the right system for your pharmaceutical research and development needs.
To meet bioanalysis needs, SCIEX offers multiple systems that support bioanalytical quantitation. Choosing the best fit for your laboratory comes down to your current and predicted future requirements. Let’s dig into the details to give you a better understanding of your options, so you can make the right decision.
Routine bioanalysis SCIEX has been selling and servicing quadrupole mass spectrometers for bioanalysis for a long time, and we pride ourselves on the performance, reliability and support offered with our LC-MS systems.
The instruments run on SCIEX OS software, which is a platform that is easy to use and reduces the burden of meeting compliance requirements. Even if you are not working in a regulated lab, developing your method on compliant-ready software could save you time in the future if the method is transferred into the regulated bioanalysis space.
For an example of the performance you can expect from SCIEX LC-MS systems, read the technical note Highly sensitive LC-MS/MS method for the quantification of fluticasone propionate in human plasma, which describes using the QTRAP 6500 system for routine bioanalytical quantitation.
Routine bioanalysis requiring higher sensitivity As technology has developed and evolved, mass spectrometers have become more sensitive, and what was once considered a nice-to-have feature is now often essential. If you need to see trace-level analytes or if your matrices are very complex, the SCIEX 7500 system is the better option for you.
To see examples of what the SCIEX 7500 system can do, read the technical notes Low-pg/mL quantification of cyclic peptides in rat plasma using microflow LC and A sensitive method for the quantification of formoterol in human plasma, which describe methods for highly sensitive bioanalytical quantitation with enhanced lower limits of quantitation (LLOQs).
A flexible quantitative/qualitative system, more selectivity or larger analytes In the last 5 years, time-of-flight (TOF) technology has become more sensitive and robust, making it more attractive within bioanalysis laboratories. The ability to offer both quantitative and qualitative information on a single system makes life easier, and the increased selectivity of TOF systems allows low-level analytes to be distinguished from complex matrices, enabling shorter run times and reduced sample preparation. In addition, as drug modalities have changed and test compounds have become larger, they have exceeded the mass range of quadrupole systems, making TOF systems essential.
Discover how the ZenoTOF 7600 system can help in your lab by reading the technical notes Sensitive quantification of insulin lispro using accurate mass spectrometry and Accomplish outstanding quantitative performance for bioanalysis of small molecule pharmaceuticals using accurate mass spectrometry, which describe highly sensitive workflows that meet the needs of routine bioanalysis in complex matrices with exceptional accuracy and precision.
Learn more For more information on the options SCIEX has for bioanalysis, please speak to your account manager, and to learn more about the benefits that sensitivity gains can bring to your bioanalytical assays, explore SCIEX technical notes that describe the ultra-sensitive quantitation capabilities of the SCIEX 7500 system in complex biological matrices.
In a recent webinar, available on demand, scientists Luiza Chrojan and Ryan Hylands from Pharmaron, provided insights into the deployment of capillary gel electrophoresis (CGE) within cell and gene therapy. Luiza and Ryan shared purity data on plasmids used for adeno-associated virus (AAV) manufacturing and data on AAV genome integrity, viral protein (VP) purity and VP ratios using the BioPhase 8800 system.
Last year, Technology Networks hosted two webinars that featured groundbreaking research utilizing SWATH DIA (data-independent acquisition) for exposomics and metabolomics. Researchers Dr. Vinicius Verri Hernandes from the University of Vienna and Dr. Cristina Balcells from Imperial College London (ICL) demonstrated how a DIA approach can be successfully implemented in small molecule analysis using the ZenoTOF 7600 system. Their innovative approaches highlight the potential of SWATH DIA to enhance the detection and analysis of chemical exposures and metabolites, paving the way for new insights into environmental health and disease mechanisms.
For as long as PFAS persist in the environment, there is no doubt they will persist in our conversations as environmental scientists. Globally, PFAS contamination has been detected in water supplies, soil and even in the blood of people and wildlife. Different countries are at various stages of addressing PFAS contamination and many governments have set regulatory limits and are working on assessing the extent of contamination, cleaning up affected sites and researching safer alternatives.
Posted by
You must be logged in to post a comment.
Share this post with your network